Skip to main content
SpringerLink
Log in

A comparison of clinical outcomes of Chinese sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease

  • Original Article
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Background

Chinese sirolimus-eluting stents (SES) have been widely used in recent years. However, the comparison of clinical outcomes between Chinese and foreign SES remains unknown.

Objectives

To compare the outcomes of Chinese SES (Firebird) with foreign SES (Cypher Select) in the treatment of patients undergoing percutaneous coronary intervention (PCI).

Methods

4000 consecutive patients treated with SESs from January 2008 to December 2009 were included in this study. Based on the differences of the stents, the patients were divided into a Chinese SES group (Firebird; n = 2008) and a foreign SES group (Cypher Select; n = 1992). Outcomes were monitored for 1 year. The primary clinical endpoint was major adverse cardiac events (MACE): a composite of death, non-fatal myocardial infarction (MI) and target-vessel revascularisation (TVR).

Results

No differences were observed in the incidence of MACE (17.8% vs. 18.6%, p = 0.514) and TVR rate (9.0% vs. 8.6%, p = 0.632) during 1-year follow-up.

Conclusions

Chinese SES and foreign SES have similar effects on 1-year clinical outcomes and safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bental T, Assali A, Vaknin-Assa H, et al. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv. 2010;76(3):374–80.

    Article  PubMed  Google Scholar 

  2. Schomig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(14):1373–80.

    Article  PubMed  Google Scholar 

  3. Beijk MA, Koch KT, Tijssen JG, et al. A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria. Coron Artery Dis. 2010 2010-11-02.

  4. Ferreira E, Araujo DV, Azevedo VM, et al. Analysis of the cost-effectiveness of drug-eluting and bare-metal stents in coronary disease. Arq Bras Cardiol. 2010;94(3):286–92. 306–12.

    Article  PubMed  Google Scholar 

  5. Cheng JM, Onuma Y, Piazza N, et al. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). Am J Cardiol. 2010;106(10):1376–81.

    Article  PubMed  Google Scholar 

  6. Hirlekar R, Patel M, Jain S, et al. Drug eluting coronary artery stents. Curr Drug Deliv. 2010 2010-10-26.

  7. Martin DM, Boyle FJ. Drug-eluting stents for coronary artery disease: A review. Med Eng Phys. 2010 2010-11-12.

  8. Park KW, Kang SH, Chung WY, et al. ‘Real world’ comparison of drug-eluting stents vs bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction. Circ J. 2010;74(6):1111–20.

    Article  PubMed  CAS  Google Scholar 

  9. Stone GW, Parise H, Witzenbichler B, et al. Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2010;56(19):1597–604.

    Article  PubMed  CAS  Google Scholar 

  10. Spaulding C, Rosencher J, Varenne O. Use of drug eluting stents in ST segment elevation myocardial infarction. Heart. 2010;96(13):1073–7.

    Article  PubMed  Google Scholar 

  11. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.

    Article  PubMed  Google Scholar 

  12. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38(7):2114–30.

    Article  PubMed  CAS  Google Scholar 

  13. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020–9.

    Article  PubMed  CAS  Google Scholar 

  14. Liu HB, Xu B, Gao RL, et al. Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry. Chinese Med J-Peking. 2006 2006-06-16(7):609–11.

  15. Xu B. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird stent. Chin Med J. 2008;121(6):492–7.

    PubMed  CAS  Google Scholar 

  16. Chen F, Gao YC, He JQ, et al. A comparison of clinical outcomes after domestic sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease. Chin J Cardiol. 2006;34(11):994–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Anzhen Hospital, Capital Medical University, Anzhenli district, Beijing, 100029, China

    M. Yu, Y.-J. Zhou, Z.-J. Wang, D.-M. Shi, Y.-Y. Liu, Y.-X. Zhao, Y.-H. Guo, W.-J. Cheng, Y.-P. Li & H.-Y. Ma

Authors
  1. M. Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y.-J. Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z.-J. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D.-M. Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y.-Y. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y.-X. Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y.-H. Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W.-J. Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Y.-P. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H.-Y. Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y.-J. Zhou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, M., Zhou, YJ., Wang, ZJ. et al. A comparison of clinical outcomes of Chinese sirolimus-eluting stents versus foreign sirolimus-eluting stents for the treatment of coronary artery disease. Neth Heart J 19, 418–422 (2011). https://doi.org/10.1007/s12471-011-0177-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12471-011-0177-2

Keywords

Search

Navigation